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in Tyk2-Deficient Mice
show a reduced T cell response after LCMV challenge.
These data imply a selective contribution of Tyk2 to
the signals triggered by various biological stimuli and
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Austria way (Velazquez et al., 1992), subsequent studies showed
Tyk2 to be activated by various other cytokines (Schind-
ler, 1999). The Jak family members have a C-terminal
catalytic domain (JH1) adjacent to a pseudokinase do-Summary
main (JH2). They share five additional Jak homology
(JH3–7) domains toward their N terminus (Pellegrini andTo assess the role of the Janus kinase (Jak) family
member Tyk2, we have generated Tyk2-/- mice. In con- Dusanter-Fourt, 1997). Studies employing a Tyk2-defi-
cient human cell line revealed that Tyk2 also plays atrast to other Jaks, where inactivation leads to a com-
plete loss of the respective cytokine receptor signal, structural role at the IFNa receptor (IFNAR) because bind-
ing of certain type I IFNs is abrogated and the cell surfaceTyk2-/- mice display reduced responses to IFNa/b and
IL-12 and a selective deficiency in Stat3 activation in level of IFNAR1 is low in these cells. The N-terminal
domains JH7 and JH6 of Tyk2 are sufficient for the interac-these pathways. Unexpectedly, IFNg signaling is also
impaired in Tyk2-/- mice. Tyk2-/- macrophages fail to tion with IFNAR1, but additional JH regions were re-
quired for the correct in vivo assembly and stabilizationproduce nitric oxide upon lipopolysaccharide induc-
tion. Tyk2-/- mice are unable to clear vaccinia virus and of the receptor (see Pellegrini and Dusanter-Fourt, 1997;
Yeh and Pellegrini, 1999).
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assembly of the IFNAR in mice; however, it is required
for a full response to type I and type II IFNs. Tyk2 plays an
essential and nonredundant role in promoting selective
immune responses, including innate host defense mecha-
nisms and specific antiviral activities.
Results
Generation of Tyk2-/- Mice
In order to disrupt the Tyk2 gene, translated exons 3–9
were targeted (Figure 1A). Homologous recombination
deleted domains known to be crucial for Tyk2 function
(Yeh and Pellegrini, 1999). Germline chimeric mice from
two independently targeted embryonic stem (ES) cell
clones were generated and mated to produce Tyk2-/-
mice (Figure 1B). Northern analysis of primary embry-
onic fibroblasts (EFs) hybridized with a murine Tyk2
cDNA probe revealed a 4.7 kb band for wild-type cells.
As expected, the Tyk2 signal intensity decreased in
Tyk21/2 EFs and the Tyk2 full-length message was not
detectable in Tyk2-/- cells (Figure 1C). A minor Tyk2 hy-
bridizing transcript appeared in Tyk21/2 and Tyk2-/- EFs
after lengthy exposure (Figure 1C, arrow). Immunopre-
cipitations (IP) and Western blotting (WB) with antibod-
ies directed against the C terminus of Tyk2 were carried
out. Tyk2-specific protein was not detectable in Tyk2-/-
primary EFs or in bone marrow–derived macrophages
(BMMs) (Figure 1D, left; Figure 2A, lanes 6–9). To further
rule out the presence of functional Tyk2 in the gene-
targeted mice, the Tyk2-deficient human cell line U1A
(11.1) (Velazquez et al., 1992) was complemented by
overexpressing murine wild-type and aberrant Tyk2
cDNAs and by fusing U1A cells with mouse Tyk21/1 and
Tyk2-/- EFs. Functional complementation of U1A cells
was assayed by two independent methods, namely
IFNa-dependent growth during a highly sensitive drug
selection and IFNa response of an endogenous induc-
ible gene. Neither the overexpression of aberrant Tyk2
cDNA nor the fusion to Tyk2-/- EFs functionally restored
the Tyk2 deficiency of U1A cells, whereas complementa-
tion with full-length Tyk2 cDNA and fusion to wild-type
murine EFs reconstituted IFNa signaling (data not
shown). On the basis of the results of these rigorous
Figure 1. Targeted Disruption of the Murine Tyk2 Gene experiments, we conclude that Tyk2 was successfully
(A) Scheme of the targeting vector. The mouse Tyk2 locus is shown inactivated in the Tyk2-/- mice. Generation of Tyk2-/- mice
at the top. In the targeting vector (middle), exons encoding the Jak by heterozygous intercrosses revealed no statistically
homology (JH) domains JH7 (partly), JH6/5, and JH4 (partly) were relevant deviation from the normal Mendelian inheri-
replaced by a neomycin resistance (GK-neo) gene cassette. A thymi-
tance. Tyk2-/- mice showed no gross abnormalities indine kinase gene (MC1-TK) cassette was used for negative selection.
development, fertility, and ontogeny of blood cells.The structure of the targeted allele is depicted at the bottom. The
position of the flanking (A) and internal (B) probes used for Southern
hybridization is marked.
(B) Southern blot analysis of genomic tail DNA from wild-type (1/1),
heterozygous (1/-), and homozygous (-/-) Tyk2 mice. XbaI digested
The shorter transcript was found to be an alternatively spliced RNADNAs were hybridized to probe A. The wild-type allele is 18.5 kb in
lacking exons 3–9. An open reading frame would give rise to alength, and the targeted allele is 6.6 kb. Hybridization to probe B
putative 90 kDa polypeptide. Experiments performed in order toconfirmed the single integration event of the targeting vector (data
prove the possible biological activity of a putative truncated Tyk2not shown).
protein are described in the text.(C) Northern blot analysis of polyA1-RNA (2 mg per lane) isolated
(D) Immunopreciptiation (IP) of Tyk2 protein bone marrow macro-from Tyk21/1, Tyk21/-, and Tyk2-/- embryonic fibroblasts (EFs) and hy-
phages (BMMs). Tyk2 was immunoprecipitated from cell homoge-bridized to a mouse Tyk2 cDNA probe and as a control to cyclophilin.
nates of BMMs and detected by Western blotting (WB) using anti-A minor aberrant transcript arising in Tyk21/- and Tyk2-/- cells is
Tyk2 antibodies (Abs). The size of the molecular mass markers inindicated by an arrow. This message together with the wild-type murine
kDa is indicated.Tyk2 mRNA was cloned and sequenced (B. M., unpublished data).
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Figure 2. Diminished but Detectable Activation of Jaks and Stats in Tyk2-/- Cells after IFN Treatment
(A–F) EFs or BMMs derived from Tyk21/1 or Tyk2-/- mice were stimulated with the indicated IFNs (1000 U/ml) for 20 min or left untreated (-).
Cells were analyzed for activation of Jaks and Stats by IP with the indicated antisera and WB with anti-phosphotyrosine Abs (aPY) or by
direct WB with anti-phosphotyrosine-Stat (aStat-PY) Abs. Protein loading was controlled by reprobing with the indicated Abs. Activation of
Tyk2 (A) and Jak1 (B) in EFs (asterisk indicates an unspecific band in Tyk2 IPs). Activation of Stat1a/b ([C], top) and reduced level of Stat1
protein in Tyk2-/- BMMs ([C], bottom). Activation of Stat2 and coprecipitation of Stat1 in EFs (D). Activation of Stat3 in BMMs (E). Activation
of Jak2 in EFs (F).
Signaling through Type I and Type II IFN Receptors detectable activation of Stat1a and Stat1b after treat-
ment with type I and II IFNs (Figure 2C, lanes 5, 7, and 9).Is Compromised but Not Abolished
in Tyk2-Deficient Mice However, as assayed by standardized WB, the level of
Stat1 protein was reduced in Tyk2-/- BMMs (Figure 2C,Tyk2 deficiency in U1A cells leads to a complete failure
to respond to IFNa and a partial defect in the IFNb bottom) and EFs (data not shown). No difference could
be detected between Tyk21/1 and Tyk2-/- EFs in the timeresponse (Velazquez et al., 1992). Therefore, we first
analyzed the activation of signaling molecules in the course of Stat1 induction after IFNa/b treatment (data
not shown). Stat2 was analyzed in a coprecipitationtype I IFN pathway and as a control in the IFNg pathway
(Stark et al., 1998). Tyk2 was phosphorylated on tyro- assay with Stat1 upon activation. Challenge of Tyk2-/-
EFs with IFNa/b revealed a reduced but detectablesines after treatment of wild-type EFs with IFNa or IFNb
but not with IFNg (Figure 2A, lanes 3–5). Importantly, phosphorylation of Stat2 and coprecipitation of phos-
phorylated Stat1 (Figure 2D, lanes 4 and 6). Strikingly,this could not be detected in Tyk2-/- EFs (Figure 2A,
lanes 7–9). Jak1 tyrosine phosphorylation was slightly IFNa/b-treated Tyk2-/- BMMs showed a complete impair-
ment of Stat3 activation (Figure 2E, lanes 7 and 8). Inreduced in Tyk2-/- EFs after treatment with IFNa or IFNb
(Figure 2B, lanes 7 and 8). Tyk2-/- BMMs showed a readily the absence of Tyk2, the activation of Jaks and Stats
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Figure 3. Expression of IFN-Responsive
Genes and of IFNAR1 in Tyk2-Deficient Mice
(A) Transcriptional response to IFNs in EFs.
Tyk21/1 and Tyk2-/- cells were treated with the
indicated IFNs (1000 U/ml) for 6 hr or left un-
treated (-). Northern blot analyses were per-
formed using 15 mg total RNA per lane and
hybridizing to Mx1 and IRF-1 and as a control
to cyclophilin.
(B) Expression of IRF-1 protein in peritoneal
macrophages (PMs) after treatment with IFNs.
Thioglycolate-elicited PMs were isolated and
stimulated with type I and II IFNs (1000 U/ml) for
4 hr. Cells were lysed and WB was performed
with anti-IRF-1 Abs (aIRF1). Protein loading
was controlled by reprobing with anti-Stat3
Abs (aStat3).
(C) Presence of IFNAR1 in membrane frac-
tions of murine EFs and BMMs. Whole cell
extracts from Tyk2-/- and Tyk21/1 EFs, and as
a negative control from IFNAR1-/- BMMs, were
fractionated in nonsoluble membrane proteins
and soluble cytoplasmic proteins by ultra-
centrifugation. The membrane pellet was dis-
solved, normalized to protein content and IP,
and WB was performed with anti-IFNAR1 Abs
(aIFNAR1).
after IFNg treatment was also decreased. Initially, we Tyk2 for high-affinity IFNa binding and stable processing
of IFNAR1 to the cell surface (Pellegrini and Dusanter-detected a slight reduction of the activation of Jak1 after
IFNg stimulus (Figure 2B, lane 9). The ability of IFNg to Fourt, 1997; Yeh and Pellegrini, 1999). In Tyk2-/- BMMs,
activate ISGF3, known to be predominantly involved in high doses of ligand (up to 5 3 104 U/ml) did not over-
the type I IFN response, was reported (Matsumoto et come the IFNa signaling defects as assayed by Stat3
al., 1999). Therefore, we analyzed the IFNg-mediated activation (data not shown). Moreover, membrane frac-
activation of Stat2, a component of ISGF3. In Tyk2-/- EFs, tions from Tyk21/1 and Tyk2-/- EFs contained similar
it was not possible to detect activated Stat2 pulling amounts of IFNAR1 (Figure 3C). Jak2 did not compen-
down activated Stat1 in a coprecipitation assay (Figure sate for the absence of Tyk2 at the IFNAR because
2D, lane 8). IFNg stimulation resulted in a similar weak Tyk2-/- cells showed no activated Jak2 after the treat-
phosphorylation of Stat3 in Tyk2-/- and Tyk21/1 BMMs ment with IFNa (Figure 2F). These data show that Tyk2-/-
(Figure 2E, lanes 5 and 9; Figure 4A, lanes 4 and 5). cells have no lowered affinity for IFNa and normal ex-
Finally, we analyzed the RNA expression of IFN-induc- pression levels of IFNAR1. In addition, no compensatory
ible genes binding ISGF3, i.e., Stat1/Stat2 heterodimers effects of Jak2 for Tyk2 deficiency could be detected.
associated with IRF-9 (e.g., Mx1) or Stat homodimers
(e.g., IRF-1) or combinations thereof (e.g., GBP-1) (Stark
Lack of Stat3 Activation, Reduced Stat4 Activation,et al., 1998). Consistent with the activation of Jaks and
and Reduced IFNg Production in Tyk2-DeficientStats, the induction of Mx1 RNA after IFNa and -b treat-
Spleen Cells after IL-12 Treatmentment and IRF-1 after IFNg treatment was reduced al-
IL-12 receptor signaling involves the Jak family mem-though clearly detectable in Tyk2-/- cells (Figure 3A, top
bers Tyk2 and Jak2 and the Stat proteins Stat3 andlanes 6 and 7 and middle lane 8, respectively). The same
Stat4 (Bacon et al., 1995; Jacobson et al., 1995). Towas observed in the response of GBP-1 to the type I
investigate the role of Tyk2 in the response to IL-12,and II IFNs (data not shown). To further investigate the
Con A-activated splenocytes were treated with IL-12apparent unresponsiveness of IRF-1 in Tyk2-/- cells to
and assayed for activation of Stats. The absence of Tyk2IFNa/b (Figure 3A, middle lanes 6 and 7), we performed
led to a complete lack of Stat3 activation (Figure 4A,WB for IRF-1 protein. IRF-1 accumulated at comparable
lanes 2 and 3) and a clearly reduced tyrosine phosphory-levels in wild-type and targeted cells after stimulation
lation of Stat4 (Figure 4B, lanes 5 and 6). IL-12 induceswith IFNs (Figure 3B). Possible differences in the time
IFNg production by activated T lymphocytes (Trinchieri,course of IRF-1 mRNA induction between Tyk2-/- and
1995). Con A-activated spleen cells of Tyk2-deficientTyk21/1 cells are currently under investigation. Thus,
mice were able to increase IFNg production upon IL-12Tyk2 deficiency leads to a partial defect in the IFNa
stimulus; however, the level of IFNg was clearly reducedand -b response and, surprisingly, also to an impairment
in comparison to IL-12-treated Tyk21/- cells. The produc-of IFNg signaling.
tion of IFNg in response to Con A alone was not de-
tectably altered (Figure 3C). These data establish theLack of Structural Requirement or Functional
requirement of Tyk2 for the full cellular response to IL-12Compensation for Tyk2 at the Murine IFNAR
and suggest that Stat3 activation selectively requiresDetailed work with the Tyk2-deficient human cell line
U1A established a kinase activity–independent role of the presence of Tyk2 in IL-12 signaling.
Mice Deficient in the Jak Family Member Tyk2
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Figure 4. Tyk2 Deficiency Causes Lack of
Stat3 Activation and Reduced IFNg Produc-
tion of Splenocytes after IL-12 Treatment
Concanavalin (Con) A-activated splenocytes
of Tyk2-/1 and Tyk2-/- mice were treated with
IL-12 (5 ng/ml) for the indicated times or left
untreated (-). Cell extracts were used for IP
and WB. Analysis of Stat activation was per-
formed as in Figure 2. (A) Activation of Stat3.
(B) Activation of Stat4. (C) Production of IFNg
in Con A-activated splenocytes after IL-12
treatment. Splenocytes were isolated and cul-
tured in the presence of Con A (1 mg/ml) or
Con A 1 IL-12 (1 ng/ml) or left untreated.
Culture supernatants were analyzed for IFNg
production by ELISA after 72 hr. The mean
IFNg production is shown for four Tyk21/- and
four Tyk-/- mice.
Tyk2 Is Not Required for IL-10 Response of
Macrophages, IL-3-, G-CSF-, or TPO-Induced
Colony Formation of Myeloid Progenitors
and IL-6- or LIF-Induced Stat3 Activation
in Embryonic Fibroblasts
Jak1, Stat1, and Stat3 have been described as part of the
IL-10R signaling cascade in mouse macrophages (Riley
et al., 1999). Using macrophages from gene-targeted
mice, it was found that the downregulation by IL-10 of
lipopolysaccharide (LPS)-stimulated TNFa production
is strictly dependent on Jak1 and Stat3 (Rodig et al.,
1998; Riley et al., 1999; Takeda et al., 1999). Tyk2 has
been reported to be phosphorylated on tyrosines after
treatment with IL-10 in responsive cell types (Finbloom
and Winestock, 1995). We therefore measured the effect
of IL-10 on the production of TNFa by BMMs. No differ-
ences in the suppression of TNFa by IL-10 were ob-
served between wild-type and targeted BMMs (Figure
5B). Consistent with these data, the activation of Stat3
(Figure 5A) and Stat1 (data not shown) by IL-10 remained
unaffected in Tyk2-/- BMMs. Tyk2 was shown to be acti-
vated by ligands using the gp130 family of cytokine
receptors (Stahl et al., 1994). To test whether Tyk2 is
required for gp130-mediated signaling, BMMs and EFs
were stimulated with IL-6 and LIF, respectively. Assaying
Stat3 activation revealed no gross differences between
Tyk2-/- and Tyk21/1 cells (data not shown). In vitro data
showed that IL-3 (Nagata and Todokoro, 1996), G-CSF
(Shimoda et al., 1997), and TPO (Sattler et al., 1995) acti-
vated Tyk2. Absence of Tyk2 did not prevent colony
formation in response to IL-3, G-CSF, and TPO (data
not shown). This is consistent with observations that for
all five cytokines other Jaks seem to play the major role Figure 5. Redundant Role of Tyk2 in IL-10 Signaling of Macro-
(Guschin et al., 1995; Shimoda et al., 1997; Parganas et phages
al., 1998; Drachmann et al., 1999). Therefore, in the bio- (A) Anti-phosphotyrosine-Stat3-specific WB of Tyk21/1 or Tyk2-/-
chemical and biological assays employed, Tyk2 is either BMMs stimulated with IL-10 (200 ng/ml) for 20 min or left untreated.
Treatment with IFNg (1000 U/ml, 20 min) was used as a stimulationnot required or redundant for the response to G-CSF,
control. The blot was reprobed with anti-Stat3 Abs.IL-3, IL-6, IL-10, LIF, and TPO.
(B) IL-10-mediated inhibition of TNFa production in BMMs. Cells
were pretreated with IL-10 (100 ng/ml) for 12 hr and subsequentlyImpairment of Type I IFN and LPS-Induced
stimulated with IFNg (1000 U/ml), LPS (50 ng/ml), a combination
NO Production in Tyk2-Deficient Macrophages thereof, or left untreated (-) for an additional 24 hr. TNFa levels were
Type 2 nitric oxide synthase (NOS2 or iNOS) is induced quantified by ELISA in the supernatants. The values represent mean
values of duplicates from two independent experiments.by IFNg, microbial products (e.g., LPS), and, in the pres-
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ence of a costimulus, by type I IFNs. NOS2-derived NO The challenge with LCMV revealed a significant (3- to
10-fold) reduction of the cytotoxic T lymphocyte (CTL)is critical for the innate and adaptive immune responses
to a wide variety of infectious pathogens (Bogdan et activity at day 8 after infection in Tyk2-/- mice (Figure
7B). The CTL activity was measured ex vivo with splenical., 2000). Wild-type and Tyk2-/- peritoneal macrophages
(PMs) were compared for their ability to produce NO in T cells on target cells coated with LCMV-specific pep-
tides. After inoculation with VV, virus was not found inresponse to IFNg, IFNa/b, LPS, or combinations thereof.
The nitrite levels after IFNg treatment were comparable the spleen of wild-type mice, while other organs such
as ovary and lung carried a high load of infectious virusin both macrophage populations (Figure 6A). In accor-
dance with previous data (Ding et al., 1988), type I IFN on day 4 after infection (Mu¨ller et al., 1994). In contrast,
infection of Tyk2-/- mice with VV resulted in elevatedalone did not induce NO production in wild-type macro-
phages unless combined with LPS (Figure 6B). In con- viral replication in the spleen (Figure 7C). Hence, Tyk2
contributes selectively to host defense against differingtrast to Tyk21/1 cells, Tyk2-/- PMs failed to produce NO
after treatment with LPS (Figure 6A) and LPS plus IFNa/b viral infections. Depending on the pathogenicity of the
virus, Tyk2 plays a redundant role in the resistance to(Figure 6B). To elucidate the underlying mechanism(s),
we assayed NOS2 expression after the stimuli described infection or is absolutely required for particular or con-
certed signaling events leading to antiviral activity.above by WB and RT-PCR. NOS2 could not be detected
in Tyk2-/- PMs in response to LPS, IFNg, or LPS plus
IFNa/b (Figure 6C, lanes 9, 10, and 12), while wild-type Discussion
PMs showed NOS2 synthesis (Figure 6C, lanes 2, 3, and
5). RT-PCR revealed that the lack of NOS2 protein is Tyk2 was the first member of the Jak family of kinases
due to the lack of LPS-inducible mRNA in Tyk2-/- PMs to be completely isolated (Firmbach-Kraft et al., 1990)
(Figure 6D). Stat1 was shown to be a converging point and originally described to be involved in IFNAR signal-
for LPS and IFNg stimuli in macrophages (Kovarik et al., ing (Velazquez et al., 1992). Our results employing Tyk2-
1998). Time course experiments in PMs showed that deficient mice demonstrate an indispensable role of
LPS alone activates Stat1, albeit in an indirect (cyclohex- Tyk2 in the induction of innate and adaptive immune
imide sensitive) fashion (Figure 6E, bottom and top pan- responses. In contrast to the obligate requirement for
els, lane 2; Gao et al., 1998). LPS also causes a signifi- the presence of all other Jak family members for the
cant increase in Stat1 levels (Figure 6E, top panel, lanes general functioning of specific cytokine receptors, Tyk2
1–5, and bottom panel, lanes 1–7). Absence of Tyk2 is redundant in the initial activation of the receptor com-
strongly reduces LPS-mediated Stat1 activation (Figure plexes investigated.
6E, top panel, lanes 10–6, and bottom panel, lanes 8–14),
as well as delays the onset (Figure 6E, top panel, com- Role of Tyk2 in Cytokine Class I and Class II
pare lanes 4–7) and shortens the duration of the re- Receptor Signaling
sponse (Figure 6E, bottom panel, compare lanes 4 and The type I IFN response is clearly impaired but not com-
11 and see note in figure legend). Earlier studies sug- pletely abolished in Tyk2-/- mice. Previous studies with
gested that short time treatment of mouse macrophages the IFNa-unresponsive mutant human cell line U1A lack-
with LPS did not result in detectable activation of any ing Tyk2 (Velazquez et al., 1992) implied a prominent
of the Jaks (Kitamura et al., 1996; Kovarik et al., 1999). role of Jak1 in type I IFN signaling, and therefore a
Nevertheless, assaying for LPS-induced Tyk2 activation subordinated role of Tyk2 was suggested. A defect in
revealed a slight increase in tyrosine phosphorylation the receptor assembly in U1A leads to loss of high-
of Tyk2 after a 2 hr stimulus (Figure 6F), the time point affinity binding of IFNa (Pellegrini and Dusanter-Fourt,
when Stat1 activation occurred (Figure 6E), while no 1997). In contrast, this function of Tyk2 appears absent
Tyk2 activation after 10 min treatment could be detected in Tyk2-/- mice. Hence, the Tyk2-dependent IFNAR1
(data not shown). These data indicate that Tyk2 plays transport mechanism is species specific, or the Tyk2-/-
an indispensable and nonredundant role in the type I phenotype of U1A is a peculiarity of this mutant or its
IFN- and/or LPS-mediated production of NO in macro- parental cell lines. Nonetheless, the stochiometry of the
phages. IFNAR in human and mice remains to be fully elucidated.
Another novel aspect is the impairment of parts of IFNg
signaling due to Tyk2 deficiency. This suggests a recep-Increased Susceptibility to Specific Viral Pathogens
in the Absence of Tyk2 tor-independent role of Tyk2 or alternatively places Tyk2
in the proximity of the IFNGR. The latter model is sup-Inoculating Tyk2-/- and Tyk21/1 mice with vesicular sto-
matitis virus (VSV), lymphocytic choriomeningitis virus ported by experimental evidence suggesting an associ-
ation of IFNAR1 and IFNGR2 and an IFNAR1-dependent(LCMV), and vaccinia virus (VV), assessed the conse-
quences of Tyk2-deficiency for host resistance to viral full functional activation of IFNg signaling components
(Takaoka et al., 2000). The emerging model of a cross-infections. No gross differences were detectable be-
tween Tyk2-/- and Tyk21/1 EFs or BMMs in the IFNa/b talk of chains belonging to differing cytokine receptors
would bring Tyk2 bound to IFNAR1 (Colamonici et al.,level-dependent appearance of cytopathic effects upon
VSV infection (data not shown). To assess the effect of 1994) into proximity of the IFNGR2-associated Jak2
(Pestka et al., 1997). Nevertheless, the role of Tyk2 inTyk2 deficiency in vivo, we inoculated wild-type, Tyk2-/-,
and IFNAR1-/- (Mu¨ller et al., 1994) mice with VSV. All an IFNAR-IFNGR superstructure is indispensible, since
neither Jak1 nor Jak2 is able to compensate for thewild- type mice survived over 12 days after infection,
while 80% of the Tyk2-/- mice and only 33% of the signaling defects. In addition, we demonstrate that Tyk2
is required for normal levels of Stat1 protein. Stat2-/-IFNAR1-/- mice were capable of surviving (Figure 7A).
Mice Deficient in the Jak Family Member Tyk2
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Figure 6. Tyk2-/- Macrophages Fail to Produce NO upon Stimulation with LPS or LPS Combined with Type I IFNs
Thioglycolate-elicited PMs were stimulated as indicated. The accumulation of nitrite in the culture supernatants was taken as an indicator of
NO production and was determined by the Griess reaction.
(A) PMs were treated with IFNg (titration 20 to 0.2 ng/ml) and LPS (titration 200 to 2 ng/ml) for 48 hr.
(B) PMs were stimulated with IFNa/b (titration 500 to 0.5 U/ml) alone or in combination with 20 ng/ml LPS for 38 hr.
(C) Expression of NOS2 protein in PMs stimulated as indicated for 48 hr. The protein concentration of the whole cell extracts was measured
and normalized prior to loading. WB was performed as described (Bogdan et al., 1997).
(D) Induction of NOS2 mRNA in LPS-treated PMs. RT-PCR was performed from RNA extracted from cells treated with LPS (100 ng/ml) for 4
hr or left untreated. Equal amounts of input cDNA was controlled by simultaneous amplification of cyclophilin.
(E) Time course of Stat1 activation in PMs after LPS treatment. Tyk21/1 or Tyk2-/- PMs were stimulated with 100 ng/ml LPS for the times
indicated. Whole cell extracts were analyzed for activation and protein level of Stat1 with the indicated Abs. Equal protein loading was
controlled by probing of the WB for Erk1. Note that the blots are equalized to Stat1 levels. Without normalization, the Stat1-PY in Tyk2-/- PMs
would be barely detectable.
(F) LPS-induced activation of Tyk2 in mouse macrophages. Bac1.2F5 cells were treated with LPS (100 ng/ml) for 2 hr. Tyk2 activation and
protein levels were assayed as in Figure 2A.
Immunity
556
Figure 7. Tyk2-/- Mice Show Differing Sus-
ceptibility to Infection with Differing Viruses
(A) Survival rate of wild-type (rhombus) com-
pared to Tyk2-/- (squares) and IFNAR-/- (trian-
gles) mice after i.v. infection with 104 pfu of
VSV. Survival was monitored for 12 days ev-
ery 24 hr. Asterisk, number of surviving mice/
total number of mice.
(B) Activity of CTLs after challenge with
LCMV. CTLs from spleens of three member
groups of Tyk2-/- (open symbols) and Tyk21/1
(closed symbols) mice were collected on day
8 after i.v. infection with 200 pfu of LCMV
and cocultured with 51Cr-labeled target cells
loaded with the LCMV-specific peptides
GP33 (top panel) or NP396 (middle panel) or
an adenovirus-derived control peptide (bot-
tom panel). Specific 51Cr-release is shown.
(C) Clearance of virus from spleen after inocu-
lation with VV. Four member groups of Tyk21/1
(closed symbols) and Tyk2-/- (open symbols)
mice were challenged with 2 3 106 pfu of VV
administered i.v., and viral titers in organs
were determined 4 days postinfection. The
values are compiled and shown for individual
mice. Horizontal bars indicate mean values.
mice also show reduced Stat1 expression as well as mediated IFNg production would be a direct causation
with the reduced activation of Stat4 in Tyk2-/- mice. Defi-an IFNg signaling deficiency phenotype (C. Schindler,
personal communication). In contrast, IFNAR1-/- cells ciency of Tyk2 results in the complete impairment of
phosphorylation of STAT3 after IFNa/b and IL-12 chal-have normal amounts of endogenous Stat1 protein (Ta-
kaoka et al., 2000). Thus, the Stat1 protein level appears lenge. In accordance with these data, it has been shown
that catalytically active Tyk2 is required for IFNa/b andto be regulated downstream of the IFNAR in a Tyk2/
Stat2-dependent manner. Taken together, a possible IL-12-mediated phosphorylation of Stat3 (Bright et al.,
1999; Rani et al., 1999). Stat3 deficiency leads to veryexplanation for our findings is the positive correlation
of Stat1 protein level with the presence of active Tyk2 early developmental stage lethality (Takeda et al., 1997).
There is evidence for requirement of Stat3 for the fulland Stat2 and/or the reduced cross-talk of the IFNR
components in the membrane superdomains. cellular response to IFNa/b (Yang et al., 1998). The bio-
logical role of Stat3 in IL-12 signaling is not yet clear.As observed for IFN signaling, Tyk2 deficiency only
partially impairs the activation of the main signal trans- Mice with a Stat3 deficiency specifically in lymphoid
and myeloid cells have not been analyzed in this contextducer in the IL-12 response, i.e., Stat4. Previous studies
have shown that the IL-12 promoted IFNg production (Takeda et al., 1998, 1999). In vitro data suggested an
involvement of Tyk2 and Stat3 in the IL-12-induced IFNgof differentiated T cells is completely disrupted in IL-12R-
deficient (Magram et al., 1996) as well as in Stat4-deficient production (Bright et al., 1999), although other work fa-
vored the importance of Tyk2 and Stat4 in this biologicalmice (Kaplan et al., 1996; Thierfelder et al., 1996). There-
fore, an obvious explanation for the reduction of IL-12- activity (see above and Ahn et al., 1998). At the IL-10R
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and gp130 utilizing receptors, no Tyk2 dependency for et al., 1995). Despite the pivotal role of IFNs in the CTL
activity induced by LCMV, it has been shown that in theStat3 could be detected. This may be explained by re-
ceptor stochiometry, i.e., the proximity of Tyk2/Stat3 absence of IFNa/b effects an alternative IL-12-depen-
dent pathway was utilized (Cousens et al., 1999). NOand/or the avaiablity of docking sites/molecules.
seems to play, if any, only a minor role in the host re-
sponse to LCMV (Bartholdy et al., 1999). Splenic leuko-Role of Tyk2 in the Production of NO by Inflammatory
cyte IFNg responses were shown to be severely im-Peritoneal Macrophages
paired during early LCMV infection; the underlyingTyk2-/- PMs fail to produce NO after stimulation with
mechanisms appeared to be IL-12 independent (PienLPS. Mouse macrophages treated with LPS produce a
and Biron, 2000). Recently, it was demonstrated thatnumber of cytokines that are known to (co-)induce (e.g.,
virus-induced type I IFNs, through activation of Stat1,IFNa/b, IFNg, TNFa, IL-12, and IL-18) or to suppress the
negatively regulate IFNg expression and that IFNa/bproduction of NO by NOS2 (e.g., IL-10 and TGFb). For
promotes IFNg production in Stat1-/- mice (Nguyen etIFNa/b, it has been formally demonstrated that its neu-
al., 2000). Therefore, the relatively mild LCMV-relatedtralization ablates the induction of NOS2 by LPS or IFNg/
phenotype in Tyk2-/- mice might be caused by the re-LPS (e.g., Gao et al., 1998). However, other endoge-
duced availability of activated Stat1, which in turn leadsnously produced cytokines that in some cases can
to a diminished downregulation of the IFNg defensecross-induce or antagonize each other might also affect
mechanisms.the expression of NOS2 through autocrine/paracrine
stimulation. Upon activation of the NOS2 gene with the
stimuli listed, the promoter has been described to en- Role of Tyk2 in Immunity and Cytokine Signaling:
gage the transcription factors IRF-1, NF-kB, HIF-1, Oct-1, Amplifier–Maintainer–Modulator–Selector?
and NF-IL6 in mouse macrophages (see Bogdan et al., The present study indicates an apparent indispensibility
2000; MacMicking et al., 1997). In addition, a Stat1 bind- of Tyk2 for innate (such as the failure to produce NO
ing site has been suggested to be required for optimal after LPS exposure) and adaptive (such as the failure
LPS/cytokine induction of the NOS2 gene (Gao et al., to develop a normal antiviral CTL activity after LCMV
1997). The complete failure of LPS to induce NO accu- challenge) immune mechanisms. The results presented
mulation (Figure 6) in the absence of Tyk2 (whereas the here support a model with Tyk2 playing an amplifying
LPS-induced production of TNFa remained unimpaired role in transducing signals by defined subgroups of cy-
[Figure 5B]) suggests that Tyk2 is the converging point tokine receptors. Tyk2 as the amplifier rather than the
for the signals controlling NOS2 activity. We show that initiator of signaling through the IFNa and gp130-con-
the underlying mechanism is the affection of NOS2 ex- taining receptors was suggested earlier in studies using
pression on transcriptional level in the absence of Tyk2, human Jak-family member-deficient cell lines (Guschin
with Stat1 being one central molecule downstream of et al., 1995; Pellegrini and Dusanter-Fourt, 1997). A se-
Tyk2, albeit acting in a protein synthesis-dependent lecting and modulating role of Tyk2 is supported by
manner. the specificity for Stat3 activation in IFNa/b and IL-12
signaling. In both response cascades, Stat3 is not con-
Selective Requirement of Tyk2 for Resistance sidered to transduce the signals for the activation of the
to Viruses major biological responses. However, it can be envis-
The selective susceptibility to viruses in Tyk2-/- mice aged that the Tyk2-Stat3 activation path accounts for
suggests that the defense against different types of in- specific subsets of functions mediated by these cyto-
fections depends on differing facets of Tyk2 action and/ kines. Finally, Tyk2 seems to be responsible for the main-
or their complexity. Resistance to VSV in mice has been tenance of normal Stat1 protein and activation levels.
shown to be mainly dependent on functioning IFNa/b sig-
Experimental Proceduresnaling (van den Broek et al., 1995). The reduced expres-
sion of the IFNa/b inducible genes in Tyk2-deficient mice
Cytokines, Antibodies, and Reagentsis apparently sufficient for establishing defense against
Purified recombinant, murine, or human cytokines were obtainedVSV in vivo. IFNg has been described to be important from Calbiochem, Genzyme Corp., GIBCO-BRL, Insight Tech., and
in protecting mice against VV infection (van den Broek R&D Systems. For the NO assays, IFNs were kindly provided by G.
et al., 1995, 2000). NO has been demonstrated to inhibit Adolf, Ernst Boehringer Institut Vienna (rmIFNg lot M3RD48) and I.
Gresser, Institute Curie Paris(mIFNa/b lot T685). Cytokines were usedVV replication (Karupiah et al., 1993), although it may
at concentrations and times as indicated in the figures. Antibodiesnot suffice for virus clearance (Rolph et al., 1996; van
(Abs) were obtained from Santa Cruz Biotechnology, New Englandden Broek et al., 2000). IL-12- and IFNb-deficient mice
Biolabs, and Upstate Biotechnology. Anti-Stat1 Abs in Figure 2Cwere shown to be highly susceptible to VV (Deonarain and D, anti-Jak2 Abs in Figure 4B, and anti-NOS2 Abs in Figure 6C
et al., 2000; van den Broek et al., 2000). The elevated were as published (Mu¨ller et al., 1993; Bogdan et al., 1997; Kovarik
replication of VV observed in Tyk2-/- spleens may be due et al., 1998). Anti-Ig peroxidase-conjugated Abs were obtained from
Sigma Aldrich and Amersham Pharmacia Biotech. The TNFa andto observed defects in the IL-12 response alone, or the
IFNg ELISA Kits were purchased from R&D Systems.combination of impaired type I and II IFN signaling and
NO production. The biological response to noncytopath-
Targeting Vector and Generation of Tyk2-/- Miceogenic LCMV is dependent on specific and overlapping
A genomic clone containing exons 3–12 of the murine Tyk2 geneeffects of the type I and type II IFN systems, since de-
was isolated from a lFixII murine 129/Sv genomic library (Stratagene)
fects in either the IFNAR or the IFNGR lead to suscepti- using the full-length human Tyk2 cDNA (GenBank Accession number
bility to LCMV, which is increased in mice with a com- X54637) as a probe. The isolated mouse Tyk2 sequences are depos-
ited in the GenBank (Accession number AF052607). A 2.4 kb EcoRI-bined receptor defect (Mu¨ller et al., 1994; van den Broek
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XhoI 59 genomic fragment and a 5.3 kb HindIII-StuI genomic 39 Synthesis (GIBCO-BRL). The sequence of the murine Tyk2 cDNA is
deposited in GenBank under Accession number AF173032.fragment were inserted into the pKOV920 vector (LexiconGenetics)
containing the neomycin resistance expression cassette (GK-neo, de-
rived from pKO SelectNeo, LexiconGenetics). The 59 end of the target- Antiviral Responses
ing construct was fused to the herpes simplex virus thymidine kinase Lymphocytic choriomeningitis virus (LCMV strain WE) was propa-
cassette (MC1-TK, derived from pKO SelectTK, LexiconGenetics). gated on L929 cells, vesicular stomatitis virus Indiana (VSV, Mudd-
Twenty micrograms SalI linearized pTyk2KO was electroporated into Summers isolate) was grown on BHK cells, and vaccinia virus strain
5 3 106 E14.1 ES cells (129/Sv/J) and grown under double selection WR (VV) was produced by infecting BSC 40 cells. Virus administra-
as described (Neubauer et al., 1998). 500 colonies were screened tion was intravenous (i.v.); the virus titers are indicated in pfu. To
for homologous recombination by PCR and targeting of four clones determine the primary LCMV-specific CTL activity, mice were infected;
was confirmed by Southern blot analysis. Two independently iso- the lytic activity of spleen cells was tested in a 5 hr 51Cr-release
lated ES clones containing the correctly targeted Tyk2 allele were assay on LCMV peptide-pulsed EL-4 target cells as described (Zim-
injected into C57BL/6 blastocysts. Chimeric mice were backcrossed merman et al., 1996). The specific 51Cr-release was calculated as
to C57BL/6 mice, and germline transmission of the mutant allele percentage ratio of experimental minus specific release and total
was confirmed. minus spontaneous release. To test susceptibility to VSV, infected
mice were monitored for survival. Susceptibility to VV was examined
as described (Binder and Kundig, 1991).Culture of Established Cell Lines and Primary Mouse Cells,
Colony Forming Assays, and Mouse Strains
NO Assay, TNFa Assay, and IFNg AssayE14.1 ES cells (129/Sv/J) were cultured as described (Neubauer et
The accumulation of nitrite in the culture supernatants of PMs wasal., 1998). The human 2fTGH cell line and the mutant U1A (11.1)
taken as an indicator of NO production and was determined by thederivative were cultured and selected as described (Mu¨ller et al.,
Griess reaction (detection limit1 mM) as described (Bogdan et al.,1993). Bac1.2F5 mouse macrophages were cultured as described
1997). For assaying TNFa, BMMs (5 3 104) were cultured in the(Kovarik et al., 1999). Mouse embryonic fibroblasts (EFs) were pre-
presence of 100 ng IL-10. After 12 hr incubation, LPS (50 ng/ml) orpared and cultured as described (Neubauer et al., 1998). EFs were
IFNg (1000U/ml) was added to the cultures for an additional 24 hr.immortalized by long time culture. Primary bone marrow macro-
Supernatants were harvested and used for measurement of TNFaphages (BMMs) were isolated from mice housed under specific
production by ELISA. For the IFNg assay, splenocytes were incu-pathogen free conditions and cultured as described (Takeda et al.,
bated alone, in the presence of 1 mg/ml Con A, or in the presence1999). Colony forming assays were performed as described (Parga-
of 1 mg/ml Con A and 1 ng/ml IL-12. After 72 hr of incubation, thenas et al., 1998; Rodig et al., 1998). Thioglycolate-elicited peritoneal
supernatant was collected, and the amount of IFNg was measuredmacrophages (PMs) were prepared and cultured as described (Bog-
by ELISA.dan et al., 1997). For the isolation of murine Concanavalin A (Con
A) splenic blast cells, spleens were explanted from mice, and single
Acknowledgmentscell suspensions were obtained by squeezing the organ using a cell
strainer. Cells (5 3 107) were incubated in the presence of 2 mg/ml
The authors are grateful for the expert technical assistance of MarionCon A (Amersham Pharmacia Biotech) in RPMI medium (Seromed)
Deutschmann, Helma Fu¨llgrabe, Anne Range, Joachim Eiweck (Vet-supplemented with penicillin/streptomycin (100 mg/ml, Seromed),
erinary University Vienna, Austria), Ulrike Huffstadt, Agnes Fu¨tterer,2-mercaptoethanol (0.05 mM, GIBCO-BRL), and FCS (10%, GIBCO-
and Evi Schaller (Technical University Munich, Germany). We wouldBRL). After 3 days of incubation, blast cells were purified performing
like to thank Drs. Michaela Fleischmann and Thomas Kolbe (IFAa Ficoll density gradient (Amersham Pharmacia Biotech), and 1 3
Tulln, Austria) for coordination of the mouse unit. The authors wish107 cells were plated in supplemented RPMI medium. IFNAR1-/- mice
to thank Drs. Sandra Pellegrini (Institut Pasteur Paris, France) forwere purchased from B&K Universal, Ltd., UK.
providing the U1A (11.1) cell line and the 6-16 probe and for helpful
discussions; Christian Schindler (Columbia University, NY, U.S.A.)Immunoprecipitation and Western Blotting
for supply of anti-Stat2-Abs; Andrew Zimiecki (University of Berne,For IPs and WB, 1–5 3 107 cells were lysed as described (Mu¨ller et
Switzerland) for anti-Jaks Abs; Ion Gresser (Institut Curie Paris,al., 1993). The cell lysate was precleared for 1 hr, at 48C in 40 ml
France) and Georg Adolf (Ernst Boehringer Institut Vienna, Austria)protein-A sepharose (Amersham Pharmacia Biotech) and 10 ml (500
for their supply of IFNs; Monika Teinfalt (Veterinary University Vi-mg) of rabbit preimmune serum (Sigma). IP was performed with the
enna, Austria) for CBC and megakaryocyte analysis; Peter Staeheliindicated Abs overnight at 48C. For Tyk2 IP, the lysis and preclear
(University of Freiburg, Germany) and Hermann Unger (Veterinarywas performed at 250 mM NaCl while the IP reaction was done at
University Vienna, Austria) for providing IFNAR1-/- mice; and Heinrich125 mM NaCl concentration. For crude extracts, the cells were lysed
Flaswinkel (Technical University Munich, Germany) for flowcytome-after stimulation directly in 23 Laemmli buffer or RIPA buffer. Frac-
try. M. K., C. L., and M. M. were supported by the Austrian Sciencetionation of cellular extracts in vesicle-plasma membrane and solu-
Foundation (FWF, P11207-GEN), H.N. and K.P. by the Deutscheble cytoplasmic protein fractions was performed as described (Eilers
Forschungsgemeinschaft (DFG, SFB 455, Pf259/2-5), and C.B. byet al., 1996). Proteins were separated on SDS-8.0% PAGE and trans-
the DFG (SFB 263, A5).ferred to nitrocellulose (GeneScreen, NEN Life Science Products).
Membranes were probed by using the indicated Abs and the ECL
Received April 14, 2000; revised September 21, 2000.detection system (Amersham Pharmacia Biotech).
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